Interferon gamma Antikörper (HRP)

Produktnummer ABIN6963841

Dieses Anti-Interferon gamma-Antikörper ist ein Maus Monoklonal-Antikörper zur Detektion von Interferon gamma in ELISA und ELISpot. Geeignet für Human und Non-Human Primate. Dieses Primary Antibody wurde in 5+ Publikationen zitiert.

Kurzübersicht für Interferon gamma Antikörper (HRP) (ABIN6963841)

Target: Interferon gamma (IFNG)

Reaktivität: Human, Non-Human Primate

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser Interferon gamma Antikörper ist konjugiert mit HRP

Applikation: ELISA, ELISpot

Klon: 7-B6-1

Produktdetails anti-Interferon gamma Antikörper (HRP)

Spezifität: Native and recombinant IFN-γ

Kreuzreaktivität (Details): The monoclonal antibody cross-reacts with IFN-γ from non-human primates.

Aufreinigung: Purified from in vitro cultures by protein G affinity chromatography.

Immunogen: Recombinant human IFN-gamma

Isotyp: IgG1

Anwendungsinformationen

Applikationshinweise: For quantification of IFN-γ in solution e.g. cell culture supernatants using ELISA and for enumeration of IFN-γ producing cells using ELISpot. 7-B6-1 is recommended as detection mAb in combination with coating mAb 1-D1K for human IFN-γ .

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: supplied storage buffer with 0.002 % Kathon CG

Lagerung: 4 °C

Informationen zur Lagerung: Store product at 4-8°C.

Haltbarkeit: 18 months

Referenzen für anti-Interferon gamma Antikörper (HRP) (ABIN6963841)

Sauermann, Radaelli, Stolte-Leeb, Raue, Bissa, Zanotto, Krawczak, Tenbusch, Überla, Keele, De Giuli Morghen, Sopper, Stahl-Hennig: "Vector Order Determines Protection against Pathogenic Simian Immunodeficiency Virus Infection in a Triple-Component Vaccine by Balancing CD4+ and CD8+ T-Cell Responses." in: Journal of virology, Vol. 91, Issue 23, (2019) (PubMed).

Cirac, Stützle, Dieckmeyer, Adhikary, Moosmann, Körber, Bauer, Witter, Delecluse, Behrends, Mautner: "Epstein-Barr virus strain heterogeneity impairs human T-cell immunity." in: Cancer immunology, immunotherapy : CII, Vol. 67, Issue 4, pp. 663-674, (2019) (PubMed).

Callendret, Vellinga, Wunderlich, Rodriguez, Steigerwald, Dirmeier, Cheminay, Volkmann, Brasel, Carrion, Giavedoni, Patterson, Mire, Geisbert, Hooper, Weijtens, Hartkoorn-Pasma, Custers, Grazia Pau et al.: "A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates. ..." in: PLoS ONE, Vol. 13, Issue 2, pp. e0192312, (2018) (PubMed).

Gubin, Zhang, Schuster, Caron, Ward, Noguchi, Ivanova, Hundal, Arthur, Krebber, Mulder, Toebes, Vesely, Lam, Korman, Allison, Freeman, Sharpe, Pearce, Schumacher, Aebersold, Rammensee, Melief, Mardis et al.: "Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens. ..." in: Nature, Vol. 515, Issue 7528, pp. 577-81, (2015) (PubMed).

Czerkinsky, Andersson, Ekre, Nilsson, Klareskog, Ouchterlony: "Reverse ELISPOT assay for clonal analysis of cytokine production. I. Enumeration of gamma-interferon-secreting cells." in: Journal of immunological methods, Vol. 110, Issue 1, pp. 29-36, (1988) (PubMed).

Details zu Interferon gamma

Target: Interferon gamma (IFNG)

Andere Bezeichnung: IFNG

Gen-ID: 3458

Pathways: Interferon-gamma Pathway, Cellular Response to Molecule of Bacterial Origin, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, ER-Nucleus Signaling, Regulation of Carbohydrate Metabolic Process, Protein targeting to Nucleus, Autophagie